Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Oculex Pharmaceuticals
company
About
Oculex Pharmaceuticals, Inc. operates as a drug delivery and pharmaceutical company.
- 101 - 250
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $50M
- Industries
- Biotechnology,Health Care,Pharmaceutical
- Founded date
- Jan 1, 1989
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Oculex Pharmaceuticals is an ophthalmic drug delivery company that is focused on the development of therapeutic products for the treatment of sight-threatening diseases.Oculex Pharmaceuticals develops Posurdex, a biodegradable release implant that delivers dexamethasone to the targeted disease site at the back of the eye.Oculex Pharmaceuticals was acquired by Allergan in November 2003.Oculex Pharmaceuticals was founded in 1989 and is based in Sunnyvale, California.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$50M
Oculex Pharmaceuticals has raised a total of
$50M
in funding over 2 rounds. Their latest funding was raised on
Oct 22, 2002 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 22, 2002 | Series B | $50M | 2 |
Perseus-Soros Biopharmaceutical Fund
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
2
Oculex Pharmaceuticals is funded by 2 investors.
Perseus-Soros Biopharmaceutical Fund
and Venture TDF
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Perseus-Soros Biopharmaceutical Fund
|
Yes | Series B |
Venture TDF
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
